Carbimazole Dosing in Adults
Carbimazole should be dosed at 20-40 mg daily initially in adults, with the specific dose determined by hyperthyroidism severity rather than body weight, as weight-based dosing is not the standard approach for this medication. 1
Initial Dosing Strategy
The evidence clearly supports severity-adjusted dosing rather than per-kilogram dosing:
- Severe hyperthyroidism (FT4 >3-4 times upper limit of normal): Start with 40 mg daily 1
- Mild to moderate hyperthyroidism (FT4 <3 times upper limit of normal): Start with 20-30 mg daily 1
Rationale for Severity-Based Dosing
Studies demonstrate that higher doses (40 mg) achieve faster normalization of thyroid function compared to lower doses (20 mg), with 83% vs 68% of patients achieving euthyroidism at 3 weeks 1. In severe hyperthyroidism (FT4 >90 pmol/L), only 40% of patients receiving 30 mg methimazole (equivalent to 40 mg carbimazole) achieved euthyroid status by 4 weeks, compared to just 15% on lower doses 1.
However, in mild hyperthyroidism, higher doses offer no advantage and increase the risk of iatrogenic hypothyroidism 2.
Maintenance Dosing
Once euthyroid status is achieved (typically within 4-12 weeks), titrate down to the minimum effective maintenance dose, generally 5-10 mg daily 3. Some patients respond well to doses as low as ≤5 mg daily 4.
Important Clinical Considerations
Carbimazole-Methimazole Equivalence
- 10 mg carbimazole = approximately 6 mg methimazole 3
- For practical purposes: 20 mg carbimazole ≈ 15 mg methimazole 1
Factors Affecting Response
- Large goiter: Slows recovery, may require higher doses 1
- High iodine intake: Delays response to treatment 1
- Adherence: Most "treatment failures" are actually non-adherence 3
Administration
Carbimazole can be given as a single daily dose due to its pharmacokinetics 1, improving adherence compared to propylthiouracil which requires multiple daily doses.
Critical Safety Warnings
Patients must be counseled to immediately stop carbimazole and contact their physician if they develop:
- Fever or sore throat (agranulocytosis risk: 0.15-0.45%) 1
- Jaundice, pale stools, or dark urine (hepatotoxicity) 3, 1
- Severe rash or joint pain (vasculitis) 1
Baseline complete blood count and liver function tests should be obtained before starting therapy 3.
Common Pitfall
Avoid the temptation to use weight-based dosing for carbimazole. Unlike many medications, carbimazole dosing is standardized based on disease severity, not patient weight. The guidelines consistently recommend fixed doses (20-40 mg) adjusted for hyperthyroidism severity, not body mass 1. Using arbitrary weight-based calculations could lead to underdosing in severe disease or overdosing in mild disease, increasing the risk of treatment failure or iatrogenic hypothyroidism.